Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_22574 | 8 | 0.18 | Mlig455_037135, Mlig455_052241 | Neo: - |
Mlig455_037135 {REF} {Length: 2874} {RNA1509_57555} {RNA1310_34538} {RNA815_2303} Mlig455_052241 {REF} {Length: 2532} {Pfam: Otopetrin [PF03189.15, score=72.0]} {Smed: dd_Smed_v6_12986_0_1, dd_Smed_v6_12986_0_1, [Score=48.9, Expect=7e-06]} {RNA1509_57555} {RNA1310_34538} {RNA815_2666} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_22574 | 8 | 0.18 | Mlig455_037135, Mlig455_052241 | Neo: - |
2 | 1.000 | - | - | - | - | 1.000 | Mlig455_037135 {REF} {Length: 2874} {RNA1509_57555} {RNA1310_34538} {RNA815_2303} Mlig455_052241 {REF} {Length: 2532} {Pfam: Otopetrin [PF03189.15, score=72.0]} {Smed: dd_Smed_v6_12986_0_1, dd_Smed_v6_12986_0_1, [Score=48.9, Expect=7e-06]} {RNA1509_57555} {RNA1310_34538} {RNA815_2666} |
|
2. | MligTC455_52508 | 76 | 1.57 | Mlig455_004455, Mlig455_021189, Mlig455_021236, Mlig455_057892 | Neo: - Age: - |
CNBD2 | 1.802 | 0.813 | - | - | - | - | 0.989 | Mlig455_004455 {REF} {Length: 969} {RNA1310_44058} {RNA815_33235} Mlig455_021189 {REF} {Length: 2436} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=59.8]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=67.0, Expect=2e-11]} {Mouse: ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=64.3, Expect=1e-10]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=55.5, Expect=4e-08]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=57.0, Expect=9e-09]} {Smed: dd_Smed_v6_19613_0_1, dd_Smed_v6_19613_0_1, [Score=160, Expect=9e-45]} {RNA1310_44058} {RNA815_33235} Mlig455_021236 {REF} {Length: 3194} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=75.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=66.6, Expect=4e-11]} {Mouse: ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=63.5, Expect=2e-10]} {Dmel: FBgn0259243, Pka-R1, Protein kinase, cAMP-dependent, regulatory subunit type 1, [Score=61.2, Expect=4e-10]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_19613_0_1, dd_Smed_v6_19613_0_1, [Score=163, Expect=1e-45]} {RNA1310_44058} {RNA815_33235} Mlig455_057892 {REF} {Length: 1962} {RNA1310_44058} {RNA815_33235} |
3. | MligTC455_52482 | 22 | 0.46 | Mlig455_042671 | Neo: - Age: - |
0.999 | - | - | - | - | - | 0.999 | Mlig455_042671 {REF} {Length: 2390} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.1]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=6e-13]} {RNA1310_47540} {RNA815_16144} | |
4. | MligTC455_42560 | 7 | 0.14 | Mlig455_068999 | Neo: - Age: - |
0.995 | - | - | - | - | - | 0.995 | Mlig455_068999 {REF} {Length: 2118} {RNA1310_112308} {RNA815_32418} | |
5. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
0.994 | - | - | - | - | - | 0.994 | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
6. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
0.994 | - | - | - | - | - | 0.994 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
7. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 0.994 | - | - | - | - | - | 0.994 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
8. | MligTC455_52483 | 36 | 0.76 | Mlig455_042704 | Neo: - Age: - |
0.994 | - | - | - | - | - | 0.994 | Mlig455_042704 {REF} {Length: 2647} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.0]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=7e-13]} {RNA1310_47540} {RNA815_16144} | |
9. | MligTC455_37602 | 11 | 0.23 | Mlig455_049973 | Neo: - Age: Up-Down-Down |
PRR9 | 0.992 | - | - | - | - | - | 0.992 | Mlig455_049973 {REF} {Length: 1124} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=47.8, Expect=5e-07]} {RNA1310_41607} {RNA815_54630} |
10. | MligTC455_35554 | 4 | 0.09 | Mlig455_035249 | Neo: - Age: - |
0.991 | - | - | - | - | - | 0.991 | Mlig455_035249 {REF} {Length: 621} {RNA1310_56217} {RNA815_38784.1} | |
11. | MligTC455_42559 | 17 | 0.36 | Mlig455_064128 | Neo: - Age: - |
0.991 | - | - | - | - | - | 0.991 | Mlig455_064128 {REF} {Length: 1837} {Pfam: Glycine rich protein [PF12810.9, score=23.2]} {RNA1310_112308} {RNA815_32418} | |
12. | MligTC455_21146 | 27 | 0.55 | Mlig455_064254 | Neo: - Age: - |
0.989 | - | - | - | - | - | 0.989 | Mlig455_064254 {REF} {Length: 2327} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=32.2]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.6]} {RNA1310_12459} {RNA815_30712} | |
13. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
0.989 | - | - | - | - | - | 0.989 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
14. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
0.987 | - | - | - | - | - | 0.987 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
15. | MligTC455_19455 | 23 | 0.48 | Mlig455_059587 | Neo: - Age: Up-Down-Down |
0.987 | - | - | - | - | - | 0.987 | Mlig455_059587 {REF} {Length: 1356} {Pfam: FAM216B protein family [PF15107.8, score=21.6]} {RNA1310_31687} {RNA815_40824} | |
16. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.987 | - | - | - | - | - | 0.987 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
17. | MligTC455_45735 | 175 | 3.64 | Mlig455_013937, Mlig455_039355 | Neo: - Age: Up-Down-Down |
0.986 | - | - | - | - | - | 0.986 | Mlig455_013937 {REF} {Length: 1369} {RNA1310_48389} {RNA815_22666} Mlig455_039355 {REF} {Length: 1299} {RNA1310_48389} {RNA815_22666} |
|
18. | MligTC455_50665 | 48 | 0.99 | Mlig455_032812 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_032812 {REF} {Length: 1550} {Pfam: Glycine rich protein [PF12810.9, score=23.7]} {RNA1310_48243.1} {RNA815_30313.2} | |
19. | MligTC455_34614 | 24 | 0.5 | Mlig455_060978 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_060978 {REF} {Length: 1770} {RNA1310_81929} | |
20. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
21. | MligTC455_10215 | 54 | 1.12 | Mlig455_012202, Mlig455_028799 | Neo: - Age: logFC(26M/2M)=-0.429 |
PCDH9, PCDHB16 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_012202 {REF} {Length: 2809} {Pfam: Cadherin domain [PF00028.19, score=133.3]; Cadherin-like [PF16184.7, score=19.8]} {Human: ENSG00000272674, PCDHB16, protocadherin beta 16, [Score=123, Expect=4e-28]; ENSG00000113211, PCDHB6, protocadherin beta 6, [Score=122, Expect=5e-28]; ENSG00000250120, PCDHA10, protocadherin alpha 10, [Score=122, Expect=1e-27]; ENSG00000204970, PCDHA1, protocadherin alpha 1, [Score=122, Expect=1e-27]; ENSG00000113212, PCDHB7, protocadherin beta 7, [Score=121, Expect=1e-27]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=119, Expect=4e-27]; ENSG00000204963, PCDHA7, protocadherin alpha 7, [Score=119, Expect=6e-27]; ENSG00000243232, PCDHAC2, protocadherin alpha subfamily C, 2, [Score=119, Expect=8e-27]; ENSG00000204961, PCDHA9, protocadherin alpha 9, [Score=118, Expect=1e-26]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=117, Expect=4e-26]; ENSG00000138650, PCDH10, protocadherin 10, [Score=117, Expect=3e-26]} {Mouse: ENSMUSG00000103442, Pcdha1, protocadherin alpha 1, [Score=127, Expect=2e-29]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=127, Expect=1e-29]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=126, Expect=5e-29]; ENSMUSG00000102692, Dchs2, dachsous cadherin related 2, [Score=125, Expect=2e-28]; ENSMUSG00000007440, Pcdha11, protocadherin alpha 11, [Score=124, Expect=1e-28]} {Dmel: FBgn0261574, kug, kugelei, [Score=117, Expect=3e-26]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=96.3, Expect=6e-20]} {Smed: dd_Smed_v6_16566_0_2, dd_Smed_v6_16566_0_2, [Score=214, Expect=5e-58]} {RNA1509_32459} {RNA1310_2760.2} {RNA815_22195} Mlig455_028799 {REF} {Length: 4449} {Pfam: Cadherin domain [PF00028.19, score=242.6]; Cadherin-like [PF16184.7, score=24.0]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=234, Expect=1e-62]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-62]; ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=226, Expect=5e-60]} {Dmel: FBgn0001075, ft, fat, [Score=196, Expect=2e-50]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=161, Expect=8e-40]} {Smed: dd_Smed_v6_16566_0_1, dd_Smed_v6_16566_0_1, [RH, Score=349, Expect=1e-103]} {RNA1509_32459} {RNA1310_2760.1, RNA1509_32459} {RNA1509_32459, RNA815_6515} |
22. | MligTC455_11274 | 19 | 0.39 | Mlig455_060650 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_060650 {REF} {Length: 656} {NoTransDecoderORF} {RNA1310_80809} {RNA815_48400} | |
23. | MligTC455_14873 | 15 | 0.31 | Mlig455_021074 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_021074 {REF} {Length: 1075} {Pfam: WSC domain [PF01822.21, score=52.6]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=46.6, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=2e-07]} {RNA1310_33352.1} {RNA815_14158.1} | |
24. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
25. | MligTC455_18003 | 26 | 0.54 | Mlig455_050296 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_050296 {REF} {Length: 1873} {RNA1509_36362} {RNA1310_57811} {RNA815_23362} | |
26. | MligTC455_21210 | 58 | 1.21 | Mlig455_054815, Mlig455_054824 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_054815 {REF} {Length: 1627} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} Mlig455_054824 {REF} {Length: 2264} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} |
|
27. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
28. | MligTC455_13101 | 40 | 0.83 | Mlig455_041354 | Neo: - Age: Up-Down-Down |
NWD2 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_041354 {REF} {Length: 5076} {Pfam: AAA ATPase domain [PF13191.8, score=35.4]; NACHT domain [PF05729.14, score=28.8]; WD domain, G-beta repeat [PF00400.34, score=23.9]} {Human: ENSG00000174145, NWD2, NACHT and WD repeat domain containing 2, [Score=353, Expect=5e-99]} {Mouse: ENSMUSG00000090061, Nwd2, NACHT and WD repeat domain containing 2, [Score=338, Expect=3e-94]} {Dmel: FBgn0038397, CG10185, [RH, Score=1016, Expect=0.0]} {Celegans: WBGene00020254, T05C3.2, [Score=738, Expect=0.0]} {Smed: dd_Smed_v6_11085_0_1, dd_Smed_v6_11085_0_1, [Score=212, Expect=4e-55]} {RNA1509_20730} {RNA1310_1147} {RNA815_11922} |
29. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
30. | MligTC455_27310 | 77 | 1.61 | Mlig455_002362 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.676 Region-enriched R2: 3.917/0.01447 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_002362 {REF} {Length: 2243} {RNA1310_27036} {RNA815_28595} | |
31. | MligTC455_38248 | 20 | 0.41 | Mlig455_059879 | Neo: - Age: - Region-enriched R4: 4.946/0.00630 |
0.983 | - | - | - | - | - | 0.983 | Mlig455_059879 {REF} {Length: 856} {RNA1509_26468} {RNA1310_62622} {RNA815_52251} | |
32. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
33. | MligTC455_11635 | 21 | 0.43 | Mlig455_033293 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_033293 {REF} {Length: 2811} {RNA1509_56255} {RNA1310_121560} {RNA815_22311} | |
34. | MligTC455_19858 | 8 | 0.17 | Mlig455_033536 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_033536 {REF} {Length: 1230} {RNA1310_25040.2} {RNA815_12562.1} | |
35. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
0.982 | - | - | - | - | - | 0.982 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
36. | MligTC455_42664 | 24 | 0.5 | Mlig455_025689 | Neo: - Age: Up-Down-Down |
0.982 | - | - | - | - | - | 0.982 | Mlig455_025689 {REF} {Length: 2068} {RNA1310_32888} | |
37. | MligTC455_19888 | 22 | 0.46 | Mlig455_066525 | Neo: - Age: - |
AC254952.1 | 0.981 | - | - | - | - | - | 0.981 | Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884} |
38. | MligTC455_28787 | 30 | 0.62 | Mlig455_043846, Mlig455_054188, Mlig455_060734 | Neo: - Age: logFC(26M/2M)=-0.737 |
ANKRD50 | 0.981 | - | - | - | - | - | 0.981 | Mlig455_043846 {REF} {Length: 665} {Pfam: DDE superfamily endonuclease [PF13358.8, score=23.1]} {Smed: dd_Smed_v6_42273_0_1, dd_Smed_v6_42273_0_1, [RH, Score=43.1, Expect=6e-06]} Mlig455_054188 {REF} {Length: 3683} {Pfam: Mab-21 protein [PF03281.16, score=27.1]} {RNA1509_27730} {RNA1310_30964} {RNA815_2387.1} Mlig455_060734 {REF} {Length: 6592} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=88.1]; Ankyrin repeats (many copies) [PF13637.8, score=65.2]; Ankyrin repeats (many copies) [PF13857.8, score=58.9]; Ankyrin repeat [PF13606.8, score=53.0]; Ankyrin repeat [PF00023.32, score=41.3]; Mab-21 protein [PF03281.16, score=25.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=86.3, Expect=3e-16]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=89.7, Expect=2e-17]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=71.6, Expect=3e-12]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=84.0, Expect=4e-16]} {RNA1509_27730} {RNA1310_24666.1} {RNA815_2426.1} |
39. | MligTC455_44578 | 12 | 0.24 | Mlig455_048995 | Neo: Int S/G2/M Age: - Region-enriched R2: 5.730/0.04221 |
0.981 | - | - | - | - | - | 0.981 | Mlig455_048995 {REF} {Length: 2090} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=110.0]} {RNA1310_22174} {RNA815_24783} | |
40. | MligTC455_08760 | 88 | 1.82 | Mlig455_032303 | Neo: - Age: - |
0.98 | - | - | - | - | - | 0.980 | Mlig455_032303 {REF} {Length: 746} {Pfam: WSC domain [PF01822.21, score=46.4]; PAN domain [PF00024.28, score=25.3]} {RNA1310_49278} {RNA815_40649} | |
41. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
42. | MligTC455_20268 | 11 | 0.23 | Mlig455_007616 | Neo: - Age: - |
0.98 | - | - | - | - | - | 0.980 | Mlig455_007616 {REF} {Length: 1727} {RNA1509_46103} {RNA1310_64930} {RNA815_36286} | |
43. | MligTC455_28785 | 30 | 0.63 | Mlig455_052183 | Neo: - |
ANKRD50 | 0.98 | - | - | - | - | - | 0.980 | Mlig455_052183 {REF} {Length: 7644} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=85.7]; Ankyrin repeats (many copies) [PF13637.8, score=62.5]; Ankyrin repeats (many copies) [PF13857.8, score=60.0]; Ankyrin repeat [PF13606.8, score=53.1]; Ankyrin repeat [PF00023.32, score=47.2]; Mab-21 protein [PF03281.16, score=33.5]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=84.0, Expect=1e-15]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=85.5, Expect=3e-16]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=76.3, Expect=1e-13]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=74.7, Expect=4e-13]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=88.2, Expect=2e-17]} {RNA1509_27730} {RNA1310_4721} {RNA815_2426.1} |
44. | MligTC455_35945 | 130 | 2.71 | Mlig455_065474 | Neo: - Age: Up-Down-Up |
0.98 | - | - | - | - | - | 0.980 | Mlig455_065474 {REF} {Length: 1654} {RNA1310_22530} {RNA815_54411} | |
45. | MligTC455_55843 | 12 | 0.25 | Mlig455_014566 | Neo: - Age: - Regeneration-upregulated R2: 4.698 Regeneration-enriched R2: 4.698 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_014566 {REF} {Length: 2456} {Pfam: C2 domain [PF00168.32, score=30.3]} | |
46. | MligTC455_30332 | 8 | 0.18 | Mlig455_009121, Mlig455_011102 | Neo: - Age: - |
0.979 | - | - | - | - | - | 0.979 | Mlig455_009121 {REF} {Length: 820} {TRANSSPLICED} {RNA1509_14366} {RNA1310_44285, RNA1509_14366} {RNA1509_14366, RNA815_22308} Mlig455_011102 {REF} {Length: 814} {TRANSSPLICED} {RNA1509_14366} {RNA1310_44285} {RNA815_22308} |
|
47. | MligTC455_43741 | 196 | 4.08 | Mlig455_018088 | Neo: - Age: Down-Up-Down |
PTBP1 | 0.979 | - | - | - | - | - | 0.979 | Mlig455_018088 {REF} {Length: 2775} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.9]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=52.7]; Occluded RNA-recognition motif [PF16842.7, score=26.8]} {Human: ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [Score=258, Expect=8e-80]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [Score=258, Expect=1e-80]; ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-76]} {Mouse: ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [Score=258, Expect=7e-81]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [Score=251, Expect=1e-78]; ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-77]} {Dmel: FBgn0011224, heph, hephaestus, [Score=249, Expect=7e-78]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [Score=234, Expect=1e-72]} {Smed: dd_Smed_v6_1868_0_1, dd_Smed_v6_1868_0_1, [Score=214, Expect=4e-64]} {RNA1509_36451} {RNA1310_3345} {RNA815_23519} |
48. | MligTC455_44176 | 89 | 1.85 | Mlig455_022911 | Neo: - Age: - |
TNKS | 0.979 | - | - | - | - | - | 0.979 | Mlig455_022911 {REF} {Length: 1883} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=67.0]; Ankyrin repeats (3 copies) [PF12796.9, score=64.6]; Ankyrin repeats (many copies) [PF13857.8, score=59.2]; Ankyrin repeat [PF13606.8, score=50.9]; Ankyrin repeat [PF00023.32, score=50.1]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=57.8, Expect=3e-08]; ENSG00000285372, AC270292.3, tankyrase, [Score=56.6, Expect=7e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=57.8, Expect=1e-08]; ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=57.8, Expect=1e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=57.8, Expect=2e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=57.4, Expect=1e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.8, Expect=9e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=55.5, Expect=8e-08]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.5, Expect=1e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=55.5, Expect=4e-08]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=55.1, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=55.1, Expect=8e-08]} {Dmel: FBgn0040752, Prosap, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.5, Expect=2e-07]} {Smed: dd_Smed_v6_2072_0_22, dd_Smed_v6_2072_0_22, [Score=62.0, Expect=4e-10]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
49. | MligTC455_44380 | 28 | 0.58 | Mlig455_000679, Mlig455_000682, Mlig455_000734 | Neo: - Age: - |
0.979 | - | - | - | - | - | 0.979 | Mlig455_000679 {REF} {Length: 966} {Pfam: PAN domain [PF00024.28, score=22.4]} {RNA1310_44307} {RNA815_33128} Mlig455_000682 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} Mlig455_000734 {REF} {Length: 1006} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} |
|
50. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
0.979 | - | - | - | - | - | 0.979 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
51. | MligTC455_39352 | 5 | 0.11 | Mlig455_015479 | Neo: - Age: - |
0.978 | - | - | - | - | - | 0.978 | Mlig455_015479 {REF} {Length: 2008} {RNA1509_46791} {RNA1310_52555.1} {RNA815_17474} | |
52. | MligTC455_44525 | 3358 | 69.96 | Mlig455_004678, Mlig455_004741, Mlig455_004755, Mlig455_004840 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.742 Region-enriched R2: 10.296/0.00000 |
0.978 | - | - | - | - | - | 0.978 | Mlig455_004678 {REF} {Length: 845} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004741 {REF} {Length: 961} {RNA1509_25712} {RNA1310_68954.1} {RNA815_35323} Mlig455_004755 {REF} {Length: 1059} {RNA1509_25712} {RNA1310_68954.2} {RNA815_35323} Mlig455_004840 {REF} {Length: 918} {RNA1509_25712, RNA1509_29691} {RNA1310_68954.2, RNA1509_25712, RNA1509_29691} {RNA1509_25712, RNA1509_29691, RNA815_35323} |
|
53. | MligTC455_13974 | 47 | 0.99 | Mlig455_057616 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.685/0.01506 |
OTOP2 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_057616 {REF} {Length: 8915} {Pfam: Otopetrin [PF03189.15, score=235.3]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=56.2, Expect=1e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=60.5, Expect=4e-09]} {Dmel: FBgn0259150, CG42265, [Score=196, Expect=3e-52]} {Celegans: WBGene00010403, otpl-8, OToPetrin-Like, [Score=114, Expect=3e-26]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=295, Expect=4e-91]} {RNA1509_7353} {RNA1310_933} {RNA815_252.1} |
54. | MligTC455_16293 | 241 | 5.01 | Mlig455_029235 | Neo: Irradiation Age: Up-Down-Down |
0.977 | - | - | - | - | - | 0.977 | Mlig455_029235 {REF} {Length: 1804} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=61.3]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=81.3, Expect=8e-17]} {RNA1509_14151} {RNA1310_17181} {RNA815_7262} | |
55. | MligTC455_16729 | 75 | 1.57 | Mlig455_013762 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.685/0.03582 |
0.977 | - | - | - | - | - | 0.977 | Mlig455_013762 {REF} {Length: 2706} {Pfam: Glycine rich protein [PF12810.9, score=24.7]; PAN domain [PF00024.28, score=18.7]} {RNA1310_22079} {RNA815_24304} | |
56. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
0.977 | - | - | - | - | - | 0.977 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
57. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
58. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
59. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
0.977 | - | - | - | - | - | 0.977 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
60. | MligTC455_41055 | 112 | 2.34 | Mlig455_044574 | Neo: - Age: Up-Down-Down Region-specific R2: 4.659 Region-enriched R2: 6.247/0.00008 |
0.977 | - | - | - | - | - | 0.977 | Mlig455_044574 {REF} {Length: 1203} {Smed: dd_Smed_v6_9736_0_1, dd_Smed_v6_9736_0_1, [Score=86.7, Expect=1e-20]} {RNA1509_58567} {RNA1310_87689} {RNA815_53353} | |
61. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
0.977 | - | - | - | - | - | 0.977 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
62. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
63. | MligTC455_53158 | 11 | 0.22 | Mlig455_033750 | Neo: - Age: - |
TNFAIP8 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_033750 {REF} {Length: 1356} {Pfam: Domain of unknown function (DUF758) [PF05527.13, score=146.4]} {Human: ENSG00000145779, TNFAIP8, TNF alpha induced protein 8, [Score=118, Expect=1e-32]; ENSG00000183578, TNFAIP8L3, TNF alpha induced protein 8 like 3, [Score=114, Expect=5e-31]} {Mouse: ENSMUSG00000062210, Tnfaip8, tumor necrosis factor, alpha-induced protein 8, [RH, Score=117, Expect=2e-32]} {Dmel: FBgn0034894, sigmar, salivary glands marred, [Score=77.0, Expect=3e-17]} {Smed: dd_Smed_v6_6451_0_1, dd_Smed_v6_6451_0_1, [Score=130, Expect=1e-37]} |
64. | MligTC455_00245 | 15 | 0.32 | Mlig455_040042 | Neo: - Age: - |
GPR17 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_040042 {REF} {Length: 1332} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Human: ENSG00000144230, GPR17, G protein-coupled receptor 17, [Score=48.9, Expect=6e-06]} {Smed: dd_Smed_v6_61185_0_1, dd_Smed_v6_61185_0_1, [Score=70.9, Expect=1e-14]} {RNA1310_142905} |
65. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
66. | MligTC455_13934 | 17 | 0.36 | Mlig455_006218 | Neo: - Age: - |
WSCD2 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_006218 {REF} {Length: 823} {Pfam: WSC domain [PF01822.21, score=53.1]; PAN domain [PF00024.28, score=24.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.3, Expect=3e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=54.7, Expect=2e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=57.8, Expect=1e-09]} {RNA1509_46267} {RNA1310_43993} {RNA815_32275.1} |
67. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
68. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 0.976 | - | - | - | - | - | 0.976 | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
69. | MligTC455_16872 | 306 | 6.37 | Mlig455_006228 | Neo: - Age: - Region-specific R2: 5.842 Region-enriched R2: 4.577/0.00000 |
0.976 | - | - | - | - | - | 0.976 | Mlig455_006228 {REF} {Length: 952} {RNA1310_48111} {RNA815_24753} | |
70. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
0.976 | - | - | - | - | - | 0.976 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
71. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
72. | MligTC455_23621 | 323 | 6.72 | Mlig455_039694, Mlig455_039749 | Neo: - Age: - Region-enriched R2: 2.235/0.02499 |
0.976 | - | - | - | - | - | 0.976 | Mlig455_039694 {REF} {Length: 2054} {RNA1509_29694} {RNA1310_14789} {RNA815_12997} Mlig455_039749 {REF} {Length: 1751} {RNA1509_29694} {RNA1310_14789, RNA1509_29694} {RNA1509_29694, RNA815_12997} |
|
73. | MligTC455_31370 | 27 | 0.55 | Mlig455_035805 | Neo: - Age: - |
ASIC1 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_035805 {REF} {Length: 3035} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.1, Expect=8e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=107, Expect=3e-24]} {RNA1310_49983} {RNA815_25991} |
74. | MligTC455_35943 | 122 | 2.55 | Mlig455_062123 | Neo: - |
FEZF2 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_062123 {REF} {Length: 3163} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=87.7]; Zinc-finger double domain [PF13465.8, score=71.3]; C2H2-type zinc finger [PF13894.8, score=56.0]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=25.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=23.1]; C2H2-type zinc finger [PF13912.8, score=21.6]} {Human: ENSG00000153266, FEZF2, FEZ family zinc finger 2, [RH, Score=337, Expect=3e-107]; ENSG00000128610, FEZF1, FEZ family zinc finger 1, [RH, Score=330, Expect=6e-105]} {Mouse: ENSMUSG00000021743, Fezf2, Fez family zinc finger 2, [RH, Score=341, Expect=7e-109]; ENSMUSG00000029697, Fezf1, Fez family zinc finger 1, [RH, Score=330, Expect=1e-104]} {Dmel: FBgn0031375, erm, earmuff, [RH, Score=343, Expect=2e-107]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [RH, Score=293, Expect=5e-94]} {Smed: dd_Smed_v6_26394_0_1, dd_Smed_v6_26394_0_1, [RH, Score=287, Expect=9e-92]} {RNA1310_14572} {RNA815_32467} |
75. | MligTC455_43315 | 118 | 2.46 | Mlig455_022312, Mlig455_069884 | Neo: - Age: logFC(26M/2M)=0.730 |
KREMEN2 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_022312 {REF} {Length: 2816} {Pfam: WSC domain [PF01822.21, score=54.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.1, Expect=5e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.4, Expect=3e-06]} {RNA1509_40165} {RNA1310_40900} {RNA815_15848} Mlig455_069884 {REF} {Length: 2143} {Pfam: WSC domain [PF01822.21, score=54.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.0, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.1, Expect=5e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.4, Expect=3e-06]} {RNA1509_40165} {RNA1310_40900} {RNA815_15848} |
76. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 0.976 | - | - | - | - | - | 0.976 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
77. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
78. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
0.976 | - | - | - | - | - | 0.976 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
79. | MligTC455_50589 | 29 | 0.61 | Mlig455_010626, Mlig455_010716 | Neo: - Age: Down-Up-Down |
0.976 | - | - | - | - | - | 0.976 | Mlig455_010626 {REF} {Length: 2021} {Pfam: Tctex-1 family [PF03645.15, score=27.5]} {RNA1310_36440} Mlig455_010716 {REF} {Length: 2038} {Pfam: Tctex-1 family [PF03645.15, score=27.2]} {RNA1310_36440} |
|
80. | MligTC455_01197 | 6 | 0.12 | Mlig455_047852 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_047852 {REF} {Length: 829} {RNA1509_18414} {RNA1310_42507} {RNA815_19425} | |
81. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
82. | MligTC455_26765 | 686 | 14.29 | Mlig455_006971 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.201/0.00046 |
0.975 | - | - | - | - | - | 0.975 | Mlig455_006971 {REF} {Length: 6360} {Pfam: Cadherin domain [PF00028.19, score=29.2]} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [RH, Score=328, Expect=1e-93]} {RNA1509_19813, RNA1509_5311} {RNA1310_621, RNA1509_19813, RNA1509_5311} {RNA1509_19813, RNA1509_5311, RNA815_183.1} | |
83. | MligTC455_29169 | 108 | 2.25 | Mlig455_002330 | Neo: - Age: Up-Down-Down |
DNAH5 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_002330 {REF} {Length: 14879} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=576.9]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=429.5]; Dynein heavy chain C-terminal domain [PF18199.3, score=313.2]; P-loop containing dynein motor region D4 [PF12780.9, score=303.1]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.8]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.2]; Microtubule-binding stalk of dynein motor [PF12777.9, score=144.8]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.4]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.5]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=21.9]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.3]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6256, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6232, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5094, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1294, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6936, Expect=0.0]} {RNA1509_39171, RNA1509_51275} {RNA1310_408, RNA1509_39171} {RNA1509_39171, RNA815_44.1} |
84. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
85. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
86. | MligTC455_39179 | 44 | 0.91 | Mlig455_052012 | Neo: - Age: Down-Up-Up |
TCTE3 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_052012 {REF} {Length: 1042} {Pfam: Tctex-1 family [PF03645.15, score=42.5]} {Human: ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=65.9, Expect=8e-13]; ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=65.9, Expect=8e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.8, Expect=1e-23]} {RNA1509_34873} {RNA1310_34743} {RNA815_18661} |
87. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
88. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
89. | MligTC455_45930 | 50 | 1.04 | Mlig455_054857 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_054857 {REF} {Length: 405} {NoTransDecoderORF} | |
90. | MligTC455_50344 | 24 | 0.51 | Mlig455_054355 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_054355 {REF} {Length: 1376} {RNA1310_56750} | |
91. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
0.975 | - | - | - | - | - | 0.975 | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
92. | MligTC455_51051 | 233 | 4.85 | Mlig455_046293 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_046293 {REF} {Length: 1585} {RNA1310_32253} | |
93. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
94. | MligTC455_17772 | 16 | 0.33 | Mlig455_047951 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_047951 {REF} {Length: 394} {NoTransDecoderORF} {RNA1509_54363} {RNA1310_57667.1} {RNA815_31588} | |
95. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
96. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
0.974 | - | - | - | - | - | 0.974 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |
|
97. | MligTC455_29045 | 127 | 2.65 | Mlig455_056054 | Neo: - Age: - Region-enriched R2: 4.858/0.00652 |
FZD5 | 0.974 | - | - | - | - | - | 0.974 | Mlig455_056054 {REF} {Length: 3655} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=389.0]; Fz domain [PF01392.24, score=85.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=554, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [Score=561, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=516, Expect=5e-176]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=368, Expect=3e-120]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [Score=522, Expect=7e-178]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
98. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
0.974 | - | - | - | - | - | 0.974 | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
99. | MligTC455_42513 | 70 | 1.45 | Mlig455_023063, Mlig455_023065 | Neo: - Age: - |
KCNC2 | 0.974 | - | - | - | - | - | 0.974 | Mlig455_023063 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} Mlig455_023065 {REF} {Length: 2276} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.7]; Ion channel [PF07885.18, score=37.0]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=7e-87]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=280, Expect=4e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=271, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=4e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=271, Expect=3e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=285, Expect=3e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=4e-94]} {Smed: dd_Smed_v6_13250_0_2, dd_Smed_v6_13250_0_2, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
100. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 0.974 | - | - | - | - | - | 0.974 | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |